In detail, both PTC (18%) and FTC (44%) cases were found to overexpress HER2 in our series, and the expression rate was significantly different between the two histotypes in favor of the follicular one. This evidence concerns the gene ERBB2 and thyroid cancer, nonmedullary, 2.